Cardinal Health Extends Pharmaceutical Distribution Deal with CVS Health Through 2032

Key Facts

1Cardinal Health announced an extension of its pharmaceutical distribution agreement with CVS Health through the end of June 2032.

Cardinal Health announced an extension of its pharmaceutical distribution agreement with CVS Health through the end of June 2032. Investing.com reported that the extension aims to maintain the strategic supply chain relationship between the pharmaceutical distributor and the retail pharmacy giant.

Securing this long-term contract with a major client like CVS provides significant revenue visibility for Cardinal Health and reduces churn risk. CAH closed at $222.5 on September 30, 2026, with the stock reaching a session high of $226.49 and a low of $222.07 on that date.